Ursprung des Netzwerks ersten Grades von Michael Haas
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 16 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Michael Haas
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Washington University in St. Louis | College/University | Doctorate Degree | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Founder | |
LeukoSite, Inc.
 LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Pharmaceuticals: Major | Chief Operating Officer Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal General Counsel | |
CardioKine, Inc.
 CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Pharmaceuticals: Major | Chairman | |
Potentia Pharmaceuticals, Inc.
 Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Pharmaceuticals: Major | Director/Board Member | |
FoldRx Pharmaceuticals LLC
 FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FoldRx Pharmaceuticals, Inc. provides drug discovery and clinical development services. It develops and discovers products focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding. The company was founded by Jeffery W. Kelly and Susan L. Lindquist in 2003 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| TETRALOGIC PHARMACEUTICALS CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
Adheron Therapeutics, Inc.
 Adheron Therapeutics, Inc. BiotechnologyHealth Technology Adheron Therapeutics, Inc. discovers and develops therapeutic drugs. The firm offers Cadherin-11 antagonists for the treatment of rheumatoid arthritis and fibrotic diseases including pulmonary fibrosis and skin fibrosis. The company was founded by David Lee, Michael B. Brenner, and David L. Castaldi in 2006 and is headquartered in Berkeley, CA. | Biotechnology | Director/Board Member President Director/Board Member | |
Galleon Pharmaceuticals, Inc.
 Galleon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galleon Pharmaceuticals, Inc. develops and manufactures medicines for breathing-control conditions. Its product pipeline addresses the needs of both acute and chronic care patients. The firm's GAL-021 product is a small molecule for intravenous administration designed to support respiratory drive in surgical and critical care patients, and in particular those high risk patients with sleep apnea who are undergoing surgery. The company was founded by James C. Mannion in 2003 and is headquartered in Horsham, PA. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| APELLIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
HealthCare Ventures LLC
 HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures LLC (HealthCare Ventures) is a venture capital firm founded in 1985 by Harold R. Werner. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor | |
| University of Pennsylvania | College/University | Doctorate Degree Undergraduate Degree | |
| Boston University | College/University | Corporate Officer/Principal Masters Business Admin Doctorate Degree | |
California Pacific Medical Center
 California Pacific Medical Center Miscellaneous Commercial ServicesCommercial Services California Pacific Medical Center operates medical centers. It offers acute and specialty care services including obstetrics, gynecology, cardiovascular, pediatrics, neurosciences, orthopedics, and organ transplantation. The company is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree | |
| State University of New York at Albany | College/University | Undergraduate Degree | |
Healthcare Ventures VII LP
 Healthcare Ventures VII LP Investment ManagersFinance HealthCare Ventures VII LP seeks investment opportunities in life science companies located in the US with an annual revenues ranging from $50 - $100 million. The fund targets companies operating in the fields of cancer therapy, infectious diseases, cardiovascular diseases, central nervous system disorders, immunotherapy, novel manufacturing technologies and novel lab scale instruments & reagents. It provides financing in the form of equity and debt convertible to equity for early and later stage capital requirements with an investment size of $1,000,000 - $20,000,000. It also makes investments in both private and public companies. | Investment Managers | Corporate Officer/Principal | |
| The Richard Nixon Foundation | Miscellaneous Commercial Services | Chairman | |
The National Center for Genome Resources
 The National Center for Genome Resources Miscellaneous Commercial ServicesCommercial Services The National Center for Genome Resources operates as a non-profit research institute for applied software engineering and next-generation sequencing to solve the preeminent challenges of 21st century biology through collaborative research and services. Its capabilities include genome, transcriptome, methylome, ChIP, small RNA, and exome sequencing, with corresponding analytical capabilities. The company is headquartered in Santa Fe, NM. | Miscellaneous Commercial Services | Director/Board Member | |
Allergan Sales LLC
 Allergan Sales LLC Medical DistributorsDistribution Services Allergan Sales LLC wholesales pharmaceutical products. It is a wholly-owned subsidiary of Allergan, Inc. The company is located in Englewood. CO | Medical Distributors | President | |
Allergan International
 Allergan International Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., Allergan International operates as an American pharmaceutical company. | Pharmaceuticals: Major | President | |
| Healthcare Pharmaceuticals, Inc. (Utah) | Director/Board Member Director/Board Member | ||
| VA Medical Center (District of Columbia) | General Government | Corporate Officer/Principal | |
Vaxxas Pty Ltd.
 Vaxxas Pty Ltd. Medical SpecialtiesHealth Technology Vaxxas Pty Ltd. develops and commercializes needle-free vaccine delivery system solutions. Its flagship products, Nanopatch, consists of an array of thousands of vaccine coated microprojections that perforate into the outer layers of the skin when applied with an applicator device. The tips of Nanopatch's microprojections are coated with a vaccine material and release this material directly to the large numbers of key immune cells immediately below the skin surface. The company was founded by Mark Kendall in August 2011 and is headquartered in Sydney, Australia. | Medical Specialties | Director/Board Member | |
| Cornell University Council | Corporate Officer/Principal | ||
| Glialogix, Inc. | Director/Board Member | ||
| Waypoint Holdings LLC | Chief Executive Officer | ||
| The University of Michigan Law School | College/University | Graduate Degree | |
| Codpiece Properties LLC | Corporate Officer/Principal | ||
| EIGER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman | |
Healthcare Strategic Partners, LLC
 Healthcare Strategic Partners, LLC Medical/Nursing ServicesHealth Services Part of HealthCare Ventures LLC, Healthcare Strategic Partners, LLC is an American company that provides healthcare services. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Nutcracker Therapeutics, Inc.
 Nutcracker Therapeutics, Inc. Information Technology ServicesTechnology Services Nutcracker Therapeutics, Inc. provides Biotechnology services. It offers push button operation, rapid cycle times and delivery vehicles. The company was founded by Igor Khandros and Benjamin Eldridge in 2018 and is headquartered in Emeryville, CA. | Information Technology Services | Director/Board Member | |
| Healthcare Partners IX LLC | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 49 |
| Israel | 2 |
| Australien | 2 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 7 |
| Finance | 5 |
| Commercial Services | 5 |
| Distribution Services | 2 |
Operativ
| Director/Board Member | 130 |
| Corporate Officer/Principal | 53 |
| President | 26 |
| Independent Dir/Board Member | 25 |
| Chairman | 18 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Augustine Lawlor | 43 |
| James Cavanaugh | 38 |
| Chris Mirabelli | 29 |
| Joseph Loscalzo | 25 |
| Doug Onsi | 25 |
| Thomas Dietz | 21 |
| Patricia Martin | 21 |
| Nissim Mashiach | 11 |
| William Li | 10 |
| Chris Richard | 9 |
| Richard Schilsky | 9 |
| Mark O’Mahony | 8 |
| Christine M. Granfield | 5 |
| Cynthia Sirard | 4 |
| Jason Baum | 4 |
- Börse
- Insiders
- Michael Haas
- Unternehmensverbindungen
